MedTrace Logo

Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram

NCT01925469 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-04-28

Study results available
· View outcomes & findings →

Summary

The objective of this study is to assess the utility of benzocaine spray versus a placebo spray in alleviating pain during and after hysterosalpingogram (HSG).

Conditions

  • Pain Relief
  • Analgesia

Interventions

DRUG

Benzocaine

DRUG

Saline spray

A saline spray will be used in the placebo group

Sponsors & Collaborators

Principal Investigators

  • Suleena K Kalra, MD, MSCE · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01925469 on ClinicalTrials.gov